Patients with MIBC whose tumors harbor mutations in the DNA damage repair genes ERCC2, ATM, or RB1 were more likely to achieve a pathologic complete response to cisplatin-based chemotherapy, according to recent data. #blcsm #urology urologytimes.com/view/gene-muta…

Ultrasonic propulsion for clearance of residual kidney stone fragments reduces relapse urologytimes.com/view/ultrasoni… via @urologytimes UW Medicine #kidneystones #healthcare #kidney

The FDA has approved the FoundationOne CDx and FoundationOneLiquid CDx tests for use as companion diagnostics in identifying patients with BRCA+ mCRPC who may benefit from treatment with olaparib plus abiraterone and prednisone/prednisolone. #pcsm urologytimes.com/view/fda-appro…

Dr. Yair Lotan recaps a #BCANTT24 session on the integration of AI into urologic care. Bladder Cancer Advocacy Network UT Southwestern Urology #urology #urologist urologytimes.com/view/yair-lota…

Gene mutations associated with response to cisplatin-based chemotherapy in MIBC urologytimes.com/view/gene-muta… via @urologytimes Analysis from the SWOG Cancer Research Network S1314 trial. Elizabeth Plimack MD Fox Chase Cancer Center David McConkey Thomas Flaig splernerMD

Important work by Victoria Edmonds Mayo Clinic Urology highlighting the need for growing advocacy for urology reimbursement to help support rural urology practices.

The U.S. FDA has granted a rare pediatric disease designation to the in vivo gene editing therapy YOLT-203 for primary hyperoxaluria type 1. #FDA #urology urologytimes.com/view/fda-grant…

Dr. Laura Bukavina (Laura Bukavina) discusses some of the challenges that women face following a diagnosis of bladder cancer. Cleveland Clinic Urology #blcsm #urology urologytimes.com/view/laura-buk…

“Our study highlights critical gaps in health care equity when it comes to treatments that have been shown effective in prolonging survival,” says Dr. Solomon Woldu (Solomon Woldu) on disparities in immunotherapy receipt. UT Southwestern Urology #kcsm #blcsm urologytimes.com/view/study-rev…

Often Because of their roles as caregivers for family members, women with bladder cancer require continuous support in prioritizing SELF-care and in navigating changes in body image. That is crucial in counseling #bladdercancer

Dr. Ana Lidia Flores-Mireles (Ana Flores-Mireles) discusses the cost effectiveness of reusable catheters. #urology urologytimes.com/view/expert-di…

Video in Urology Times: Armine Smith recaps #BCANTT24 session on oligometastatic bladder cancer. Click here to watch the video: urologytimes.com/view/armine-k-…

“We saw in the survey that men are concerned with how the health decisions they make now will affect them in the future,” says Petar Bajic, MD, on data from Cleveland Clinic’s MENtion It survey. Cleveland Clinic Urology Petar Bajic #urology urologytimes.com/view/survey-re…

Published data from the observational DEAR study indicate that darolutamide is associated with more favorable tolerability compared with enzalutamide and apalutamide in the treatment of patients with nmCRPC. Dan George Duke Urology #pcsm #urology urologytimes.com/view/darolutam…

Dr. Stacy Loeb (Stacy Loeb, MD) shares sources of burnout as well as ways that she finds fulfillment in her career, including obtaining a board certification in lifestyle medicine. Amy Pearlman, MD #urology #urologist urologytimes.com/view/dr-stacy-…

Dr. Yair Lotan highlights the development and validation of an AI algorithm designed to predict response to BCG in patients with NMIBC. UT Southwestern Urology #blcsm #urology urologytimes.com/view/yair-lota…

The American Cancer Society (American Cancer Society) has launched the National Prostate Cancer Roundtable to address the “alarming” rise in prostate cancer diagnoses. #pcsm #urology urologytimes.com/view/acs-launc…

Dr. Kevin Zorn (Dr_KevinZorn) highlights the evolution of Aquablation that enabled a study of same-day discharge for the procedure. #BPH #urology urologytimes.com/view/kevin-zor…

In this @urologytimes interview, Robert D. Hoy, MPAS, PA-C, shares how he communicates with urologists in his practice in order to enhance collaboration. bit.ly/3Tiqz50

ConTIPI Medical has announced a partnership with EVERSANA to support the US commercial launch of the ProVate device, a vaginal ring pessary for patients with pelvic organ prolapse. #urology urologytimes.com/view/collabora…